butaclamol has been researched along with Chronic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, ML; Costiloe, JP; Fulkerson, FG; Paredes, A; Wood, F | 1 |
1 trial(s) available for butaclamol and Chronic Disease
| Article | Year |
|---|---|
Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Butaclamol; Chronic Disease; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Schizophrenia; Time Factors | 1977 |